Eli Lilly

Page 4 of 7

WHO
Health

A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says

By Naomi Kresge, Angela Feliciano and Bloomberg
March 1, 2024
Minnesotans can buy insulin for just $35 a month over the next 5 years under a state settlement with Eli Lilly
Health

Minnesotans can buy insulin for just $35 a month over the next 5 years under a state settlement with Eli Lilly

By Steve Karnowski and The Associated Press
February 8, 2024
Novo Nordisk hits $500B market value, climbing closer to the $1T club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year
Retail

Novo Nordisk hits $500B market value, climbing closer to the $1T club as it forecasts Wegovy and Ozempic will juice another 29% jump in profits this year

By
January 31, 2024
North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030
Health

North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030

By Simone Foxman, Madison Muller and Bloomberg
January 27, 2024
Alphabet’s Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery
Health

Alphabet’s Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery

By Susanne Barton and Bloomberg
January 8, 2024
Eli Lilly and Company says its popular drugs Mounjaro and Zepbound, also known as GLP-1s, are not meant for those without obesity or type 2 diabetes.

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of for diabetes and obesity

By
January 4, 2024
Career advice from the CFOs of Dell, Eli Lilly, and Marriott—3 women who have each spent 20-plus years climbing the ladder at one company
Newsletters

Career advice from the CFOs of Dell, Eli Lilly, and Marriott—3 women who have each spent 20-plus years climbing the ladder at one company

By
December 4, 2023
Weight loss drugs are all the rage.
Health

Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro

By Madison Muller and Bloomberg
December 1, 2023
Lars Fruergaard Jorgensen holding a microphone in one hand and paper flashcards in the other hand
Health

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

By
November 27, 2023
a box of wegovy injectables
Retail

Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports

By
November 13, 2023
FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy
Health

FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy

By Madison Muller and Bloomberg
November 8, 2023
picture of four wegovy injections lined up
Health

Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

By
November 3, 2023
Eli Lilly
Health

New weight-loss blockbuster drug emerges from study showing Mounjaro helps people lose 25% of their body weight or 60 pounds on average

By Jonel Aleccia and The Associated Press
October 15, 2023
TikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash
Tech

TikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash

By
September 19, 2023
woman measuring her waist with a tape measure.
Health

Blockbuster weight loss drugs Ozempic and Wegovy cost Americans up to 10 times more than what other countries pay, research shows

By
August 18, 2023

Most Popular